Our prior trials with HNSCC patients have shown that treatment with vitamin D metabolites reduces levels of immune inhibitory immature CD34+ cells, increase levels of mature dendritic cells, stimulates both intratumoral immune infiltration and peripheral blood immune reactivity, and prolongs the post-surgical period prior to tumor recurrence [26,35,36,37,38]. The gene discussed is CD34; the disease is neoplasm.